Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trials

Nature Clinical Practice Oncology volume 4, pages 508–509 (2007)Cite this article

boxed-textEinhorn LH et al. (2007) Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant. J Clin Oncol 25: 513–516

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kondagunta GV et al. (2006) Chemotherapy for advanced germ cell tumors. J Clin Oncol 24: 5493–5502

    Article  CAS  Google Scholar 

  2. Kondagunta GV et al. (2005) Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23: 6549–6555

    Article  CAS  Google Scholar 

  3. Kondagunta GV et al. (2007) Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. J Clin Oncol 25: 85–90

    Article  CAS  Google Scholar 

  4. Kollmannsberger C et al. (2004) Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group. J Clin Oncol 22: 108–114

    Article  CAS  Google Scholar 

  5. Einhorn LH et al. (2006) Salvage chemotherapy with high dose carboplatin + etoposide (HDCE) and peripheral blood stem cell transplant (PBSCT) in patients with germ cell tumors (GCT) [abstract #4549]. J Clin Oncol 24 (Suppl 18)

Download references

Acknowledgements

The synopsis was written by Tamsin Osborne, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. DR Feldman is a Fellow in Medical Oncology and Hematology in the Department of Medicine and GJ Bosl is The Patrick M Byrne Chair in Clinical Oncology in the Department of Medicine, Memorial Sloan–Kettering Cancer Center, New York, NY, USA.,

    Darren R Feldman & George J Bosl

Authors
  1. Darren R Feldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George J Bosl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George J Bosl.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feldman, D., Bosl, G. Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trials. Nat Rev Clin Oncol 4, 508–509 (2007). https://doi.org/10.1038/ncponc0904

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0904

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing